539 related articles for article (PubMed ID: 29860457)
1. Changes in Retinal Microvasculature and Visual Acuity After Antivascular Endothelial Growth Factor Therapy in Retinal Vein Occlusion.
Winegarner A; Wakabayashi T; Fukushima Y; Sato T; Hara-Ueno C; Busch C; Nishiyama I; Shiraki N; Sayanagi K; Nishida K; Sakaguchi H; Nishida K
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2708-2716. PubMed ID: 29860457
[TBL] [Abstract][Full Text] [Related]
2. RETINAL MICROVASCULATURE AND VISUAL ACUITY AFTER INTRAVITREAL AFLIBERCEPT IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study.
Winegarner A; Wakabayashi T; Hara-Ueno C; Sato T; Busch C; Fukushima Y; Sayanagi K; Nishida K; Sakaguchi H; Nishida K
Retina; 2018 Oct; 38(10):2067-2072. PubMed ID: 28902097
[TBL] [Abstract][Full Text] [Related]
3. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of aflibercept for the treatment of persistent macular oedema secondary to retinal vein occlusions in eyes not responsive to long-term treatment with bevacizumab or ranibizumab.
Spooner K; Fraser-Bell S; Hong T; Chang A
Clin Exp Ophthalmol; 2020 Jan; 48(1):53-60. PubMed ID: 31498950
[TBL] [Abstract][Full Text] [Related]
5. Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.
Babiuch AS; Han M; Conti FF; Wai K; Silva FQ; Singh RP
JAMA Ophthalmol; 2019 Jan; 137(1):38-46. PubMed ID: 30286219
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Choroidal Thickness, Foveal Avascular Zone, and Macular Capillary Density in Macular Edema Secondary to Branch Retinal Vein Occlusion Treated with Ranibizumab or Aflibercept-A Prospective Study.
Huang YT; Wang I; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Bair H; Lin JM; Chen WL; Chen CH; Wu WC; Tsai YY
Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454378
[TBL] [Abstract][Full Text] [Related]
7. Retinal Microvasculature and Visual Acuity in Eyes With Branch Retinal Vein Occlusion: Imaging Analysis by Optical Coherence Tomography Angiography.
Wakabayashi T; Sato T; Hara-Ueno C; Fukushima Y; Sayanagi K; Shiraki N; Sawa M; Ikuno Y; Sakaguchi H; Nishida K
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2087-2094. PubMed ID: 28388705
[TBL] [Abstract][Full Text] [Related]
8. Retinal Microvasculature and Visual Acuity after Intravitreal Aflibercept in Diabetic Macular Edema: An Optical Coherence Tomography Angiography Study.
Busch C; Wakabayashi T; Sato T; Fukushima Y; Hara C; Shiraki N; Winegarner A; Nishida K; Sakaguchi H; Nishida K
Sci Rep; 2019 Feb; 9(1):1561. PubMed ID: 30733512
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Microvascular Structure Changes after Conbercept Treatment on Macular Edema Secondary to Retinal Vein Occlusion.
Song W; Jiao W; Li F; Ma A; Zhao B
Biomed Res Int; 2020; 2020():9046781. PubMed ID: 32685542
[TBL] [Abstract][Full Text] [Related]
10. Effects of Switching to Aflibercept in Treatment Resistant Macular Edema Secondary to Retinal Vein Occlusion.
Spooner K; Fraser-Bell S; Hong T; Chang A
Asia Pac J Ophthalmol (Phila); 2020; 9(1):48-53. PubMed ID: 31990746
[TBL] [Abstract][Full Text] [Related]
11. CORRELATION OF MICROVASCULAR STRUCTURES ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY WITH VISUAL ACUITY IN RETINAL VEIN OCCLUSION.
Kang JW; Yoo R; Jo YH; Kim HC
Retina; 2017 Sep; 37(9):1700-1709. PubMed ID: 27828907
[TBL] [Abstract][Full Text] [Related]
12. Effect of aflibercept on refractory macular edema associated with central retinal vein occlusion.
Cohen MN; Houston SK; Juhn A; Ho AC; Regillo CD; Vander J; Chiang A
Can J Ophthalmol; 2016 Oct; 51(5):342-347. PubMed ID: 27769324
[TBL] [Abstract][Full Text] [Related]
13. EVALUATION OF MACULAR ISCHEMIA IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study.
Ghashut R; Muraoka Y; Ooto S; Iida Y; Miwa Y; Suzuma K; Murakami T; Kadomoto S; Tsujikawa A; Yoshimura N
Retina; 2018 Aug; 38(8):1571-1580. PubMed ID: 28671896
[TBL] [Abstract][Full Text] [Related]
14. Impact of Baseline Retinal Nonperfusion and Macular Retinal Capillary Nonperfusion on Outcomes in the COPERNICUS and GALILEO Studies.
Feltgen N; Ogura Y; Boscia F; Holz FG; Korobelnik JF; Brown DM; Heier JS; Stemper B; Rittenhouse KD; Asmus F; Ahlers C; Vitti R; Saroj N; Mitchell P
Ophthalmol Retina; 2019 Jul; 3(7):553-560. PubMed ID: 31277796
[TBL] [Abstract][Full Text] [Related]
15. Microvascular Retinal and Choroidal Changes in Retinal Vein Occlusion Analyzed by Two Different Optical Coherence Tomography Angiography Devices.
Costanzo E; Parravano M; Gilardi M; Cavalleri M; Sacconi R; Aragona E; Varano M; Bandello F; Querques G
Ophthalmologica; 2019; 242(1):8-15. PubMed ID: 30721901
[TBL] [Abstract][Full Text] [Related]
16. Optical coherence tomography angiography findings in patients with branch retinal vein occlusion treated with Anti-VEGF.
Ciloglu E; Dogan NÇ
Arq Bras Oftalmol; 2020; 83(2):120-126. PubMed ID: 31778447
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between Visual Acuity and Retinal Thickness During Anti-Vascular Endothelial Growth Factor Therapy for Retinal Diseases.
Ou WC; Brown DM; Payne JF; Wykoff CC
Am J Ophthalmol; 2017 Aug; 180():8-17. PubMed ID: 28549848
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome after switching therapy from ranibizumab and/or bevacizumab to aflibercept in central retinal vein occlusion.
Pfau M; Fassnacht-Riederle H; Becker MD; Graf N; Michels S
Ophthalmic Res; 2015; 54(3):150-6. PubMed ID: 26413794
[TBL] [Abstract][Full Text] [Related]
19. OCT Angiography Study of the Macula in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept.
Dastiridou A; Karathanou K; Riga P; Anagnostopoulou S; Balasubramanian S; Mataftsi A; Brazitikos P; Ziakas N; Androudi S
Ocul Immunol Inflamm; 2021 Jul; 29(5):926-931. PubMed ID: 31951761
[No Abstract] [Full Text] [Related]
20. Individualized treat-and-extend regime for optimization of real-world vision outcome and improved patients' persistence.
Volkmann I; Knoll K; Wiezorrek M; Greb O; Framme C
BMC Ophthalmol; 2020 Mar; 20(1):122. PubMed ID: 32228517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]